Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joel G Winner"'
Autor:
Michael R. Jablonski, Lucas R Watterson, Joel G. Winner, Bryan Dechairo, Wang Yongbao, Gunselman Sandra, King Nina
Publikováno v:
Personalized Medicine. 15:189-197
Aim: The aim of this study was to validate the analytical performance of a combinatorial pharmacogenomics test designed to aid in the appropriate medication selection for neuropsychiatric conditions. Materials & methods: Genomic DNA was isolated from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc865214b92de00c65f8a9c863b73c3e
https://doi.org/10.2217/pme-2017-0094
https://doi.org/10.2217/pme-2017-0094
Publikováno v:
Pharmacogenomics and Personalized Medicine
Eve S Fields,1 Raymond A Lorenz,2 Joel G Winner2 1Northwest Center for Community Mental Health, Reston, VA, USA; 2Assurex Health, Mason, OH, USA Abstract: This report describes two cases in which pharmacogenomic testing was utilized to guide medicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3f85109b3a9d98bada374b36ba5e5b
http://europepmc.org/articles/PMC4993396
http://europepmc.org/articles/PMC4993396
Autor:
Susan Garavaglia, Andrew G Marshak, Seth Goldfarb, Josiah D. Allen, Joseph M Carhart, Joel G. Winner, Kelly K Parsons, Gabriela Lavezzari, C Anthony Altar, Bryan Dechairo
Publikováno v:
Current Medical Research and Opinion. 31:1633-1643
The objective of this project was to determine pharmacy cost savings and improvement in adherence based on a combinatorial pharmacogenomic test (CPGx ) in patients who had switched or added a new psychiatric medication after having failed monotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c24937c500cc7438bee6d343016c97c0
https://doi.org/10.1185/03007995.2015.1063483
https://doi.org/10.1185/03007995.2015.1063483
Autor:
Joel G. Winner, C Anthony Altar, Daniel K. Hall-Flavin, Bryan Dechairo, Josiah D. Allen, Joseph M Carhart
Publikováno v:
Complex Psychiatry. 1:145-155
DNA of 258 patients with treatment-resistant depression was collected in three 8-10 week, two-arm, prospective clinical trials. Forty-four allelic variations were measured in genes for the cytochrome P450 (CYP) enzymes CYP2D6, CYPC19, and CYP1A2, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faec7f0adafe38b994938c17e99bbfa0
https://doi.org/10.1159/000430915
https://doi.org/10.1159/000430915
Publikováno v:
Applied and Translational Genomics, Vol 5, Iss C, Pp 47-49 (2015)
Applied & Translational Genomics
Applied & Translational Genomics
Prescribing safe and effective medications is a challenge in psychiatry. While clinical use of pharmacogenomic testing for individual genes has provided some clinical benefit, it has largely failed to show clinical utility. However, pharmacogenomic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e081af5916f1979f757614595f7bd95
Publikováno v:
Academic Psychiatry. 34:115-118
Objective The authors ascertained the amount of training in psychiatric genomics that is provided in North American psychiatric residency programs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b0d14c0c55f3610af554117a6b7cfc7
https://doi.org/10.1176/appi.ap.34.2.115
https://doi.org/10.1176/appi.ap.34.2.115
Autor:
Joel G, Winner, Bryan, Dechairo
Publikováno v:
The Yale Journal of Biology and Medicine
Pharmacogenomic testing in mental health has not yet reached its full potential. An important reason for this involves differentiating individual gene testing (IGT) from a combinatorial pharmacogenomic (CPGx) approach. With IGT, any given gene reveal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61edeb62238d68a7696655698f0513e6
https://pubmed.ncbi.nlm.nih.gov/26604861
https://pubmed.ncbi.nlm.nih.gov/26604861
Autor:
Joel G. Winner, Josiah D. Allen, Joseph M Carhart, Daniel K. Hall-Flavin, C A Altar, Bryan Dechairo
Publikováno v:
The pharmacogenomics journal. 15(5)
In four previous studies, a combinatorial multigene pharmacogenomic test (GeneSight) predicted those patients whose antidepressant treatment for major depressive disorder resulted in poorer efficacy and increased health-care resource utilizations. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40acf1bb3146e5a1a68df9a15fcf9966
https://pubmed.ncbi.nlm.nih.gov/25686762
https://pubmed.ncbi.nlm.nih.gov/25686762
Autor:
Maureen S. Drews, Joel G. Winner, David A. Mrazek, Josiah D. Allen, Brian D. Proctor, Joseph M Carhart, Linda L. Eisterhold, Daniel K. Hall-Flavin, Karen Snyder, Jennifer R. Geske
Publikováno v:
Pharmacogenetics and genomics. 23(10)
The objective was to evaluate the potential benefit of an integrated, five-gene pharmacogenomic test and interpretive report (GeneSight) for the management of psychotropic medications used to treat major depression in an outpatient psychiatric practi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::622145d10bea25fa41a27d6327b04838
https://pubmed.ncbi.nlm.nih.gov/24018772
https://pubmed.ncbi.nlm.nih.gov/24018772
Autor:
Joanna M. Biernacka, L L Eisterhold, Josiah D. Allen, J J Jordan, Maureen S. Drews, Joel G. Winner, David A. Mrazek, R S Nesheim, Daniel K. Hall-Flavin, Karen Snyder
Publikováno v:
Translational Psychiatry
The objective of this study was to evaluate the potential benefit of utilizing a pharmacogenomic testing report to guide the selection and dosing of psychotropic medications in an outpatient psychiatric practice. The non-randomized, open label, prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b032899f3ec4757a1c11bd96f8f7ede
https://pubmed.ncbi.nlm.nih.gov/23047243
https://pubmed.ncbi.nlm.nih.gov/23047243